Lantheus Holdings (LNTH) Non-Current Debt (2014 - 2026)
Lantheus Holdings (LNTH) reported Non-Current Debt of $569.6 million for Q1 2026, up 0.62% year-over-year from $566.1 million in Q1 2025, and little changed quarter-over-quarter from $568.7 million in Q4 2025.
Lantheus Holdings (LNTH) Non-Current Debt (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 13 years of Non-Current Debt data on file, last reported at $569.6 million in Q1 2026.
- Non-Current Debt for Q1 2026 came in at $569.6 million, up 0.62% year-over-year; the trailing twelve-month figure through Mar 2026 was $569.6 million (up 0.62% YoY), and the FY2025 annual result was $568.7 million, up 0.6% from the prior year.
- Non-Current Debt held at $569.6 million in Q1 2026 per LNTH's latest filing, from $568.7 million in the prior quarter.
- Over five years, Non-Current Debt peaked at $569.6 million in Q1 2026 and troughed at $613000.0 in Q3 2024.
- A 5-year average of $458.6 million and a median of $561.7 million in 2023 frame the typical range for Non-Current Debt.
- The sharpest annual moves came in 2024 and 2025: Non-Current Debt tumbled 99.89% in 2024, then surged 92548.78% in 2025.
- A 5-year view of Non-Current Debt shows it stood at $557.7 million in 2022, then rose by 0.71% to $561.7 million in 2023, then advanced by 0.64% to $565.3 million in 2024, then gained by 0.6% to $568.7 million in 2025, then gained by 0.16% to $569.6 million in 2026.
- Business Quant data shows LNTH's Non-Current Debt at $569.6 million in Q1 2026, $568.7 million in Q4 2025, and $567.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 14.02 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 9.05 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 3.92 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 1.48 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 569.60 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 569.60 Mn |
| Mar 31, 2026 | 569.60 Mn |
| Dec 31, 2025 | 568.68 Mn |
| Dec 31, 2025 | 568.68 Mn |
| Sep 30, 2025 | 567.94 Mn |
| Sep 30, 2025 | 567.94 Mn |
| Jun 30, 2025 | 566.85 Mn |
| Jun 30, 2025 | 566.85 Mn |
| Mar 31, 2025 | 566.10 Mn |
| Mar 31, 2025 | 566.10 Mn |
| Dec 31, 2024 | 565.28 Mn |
| Dec 31, 2024 | 565.28 Mn |
| Sep 30, 2024 | 613,000.00 |
| Sep 30, 2024 | 613,000.00 |
| Jun 30, 2024 | 563.19 Mn |
| Jun 30, 2024 | 563.19 Mn |
| Mar 31, 2024 | 562.47 Mn |
| Mar 31, 2024 | 562.47 Mn |
| Dec 31, 2023 | 561.67 Mn |
| Dec 31, 2023 | 561.67 Mn |